Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir in Chronic Hepatitis B
NCT01369212Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Nov 2012
- Primary completion
- Mar 2021
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 2
01
Overview
A Phase 3 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Nov 2012; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01369212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01369212.